Status:
UNKNOWN
Developmental Regression-related Disease Research and Achievement Transformation Innovation Team
Lead Sponsor:
Chen Li
Conditions:
ASD
GDD
Eligibility:
All Genders
1-7 years
Brief Summary
The incidence rate of developmental regression is gradually increasing. In the early stages of children's development, both ASD and DD patients can experience developmental regression, which in turn a...
Detailed Description
1. Procedures. Children who visited the Children's Health Department between 2021.12 and 2024.12., met the inclusion criteria, and had informed consent signed by their parents. Developmental assessmen...
Eligibility Criteria
Inclusion
- （1）ASD patients：
- Patients diagnosed with autism spectrum disorder based on DSM-5 by 2 child care physicians and/or psychiatrists with associate senior professional titles or above.
- Aged 1-7years
- （2）DDpatients：
- Patients diagnosed with global developmental delay based on DSM-5 by 2 child care physicians and/or psychiatrists with associate senior professional titles or above.
- Aged 1-7 years
Exclusion
- Exclude other histories of mental illness, neurological diseases and severe physical diseases, exclude patients with a history of substance and drug abuse, and patients who have not taken risperidone and other related antipsychotic drugs.
Key Trial Info
Start Date :
November 30 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT06155214
Start Date
November 30 2023
End Date
December 31 2024
Last Update
December 4 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Growth,Development and Mental Health of Children and Adolescents Center
Chongqing, Chongqing Municipality, China, 400014